- Home
- PFC vs CRMD Comparison
PFC vs CRMD Comparison
Compare PFC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFC
- CRMD
- Stock Information
- Founded
- PFC 1920
- CRMD 2006
- Country
- PFC United States
- CRMD United States
- Employees
- PFC N/A
- CRMD N/A
- Industry
- PFC Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- PFC Finance
- CRMD Health Care
- Exchange
- PFC Nasdaq
- CRMD Nasdaq
- Market Cap
- PFC 898.9M
- CRMD 753.6M
- IPO Year
- PFC N/A
- CRMD 2010
- Fundamental
- Price
- PFC $27.79
- CRMD $10.15
- Analyst Decision
- PFC Hold
- CRMD Strong Buy
- Analyst Count
- PFC 4
- CRMD 6
- Target Price
- PFC $22.50
- CRMD $15.67
- AVG Volume (30 Days)
- PFC 211.8K
- CRMD 1.5M
- Earning Date
- PFC 01-21-2025
- CRMD 03-11-2025
- Dividend Yield
- PFC 4.45%
- CRMD N/A
- EPS Growth
- PFC N/A
- CRMD N/A
- EPS
- PFC 1.98
- CRMD N/A
- Revenue
- PFC $249,701,000.00
- CRMD $12,262,234.00
- Revenue This Year
- PFC N/A
- CRMD N/A
- Revenue Next Year
- PFC $7.69
- CRMD $246.41
- P/E Ratio
- PFC $14.07
- CRMD N/A
- Revenue Growth
- PFC N/A
- CRMD 41184.20
- 52 Week Low
- PFC $18.63
- CRMD $2.89
- 52 Week High
- PFC $29.63
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- PFC 56.53
- CRMD 40.80
- Support Level
- PFC $25.11
- CRMD $11.90
- Resistance Level
- PFC $28.46
- CRMD $12.67
- Average True Range (ATR)
- PFC 0.86
- CRMD 0.73
- MACD
- PFC 0.29
- CRMD -0.27
- Stochastic Oscillator
- PFC 70.79
- CRMD 2.12
About PFC Premier Financial Corp.
Premier Financial Corp is a financial holding company that operates as a community banking and financial services corporation. It offers a broad range of financial services through its subsidiaries including checking accounts, savings accounts, certificates of deposit, real estate mortgage loans, commercial loans, consumer loans, home equity loans, and trust and wealth management services.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.